• 11/26/2024

Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant

Wall Street Journal

The Swiss drugmaker received FDA approval to expand U.S. production of its closely watched cancer drug Pluvicto,

https://www.wsj.com/articles/novartis-to-make-pluvicto-radioligand-therapy-at-indianapolis-plant-03675285